SAPIEN BIOSCIENCES PRIVATE LIMITED

In their own words

Sapien is India’s pioneer in biobanking, being its largest and only commercial biobank, founded by pharma industry experts Dr. Jugnu Jain and Mr. Sreevatsa Natarajan. It puts ‘medical waste’ to use for healthcare innovation. The biobank has been established in a unique partnership with Apollo Hospitals, a pan-India network of 69 multi-specialty hospitals, hence avoiding regional or disease bias in the biobank. Sapien is expanding to other public and private hospitals to increase its capacity and diversity of patients. Challenges from streamlining & integrating multiple hospitals, each with its own workflow, IT databases and practices have been overcome using learnings from past 6 years such that the synergy of scale is now evident. Sapien has already acquired >85,000 cases and expects to cross 250,000 in 3 years for which it seeks scale-up funds. With funding, Sapien can rapidly bring biobanking to high quality public and private hospitals and save valuable samples and associated data from being lost or discarded. These biospecimens and associated digitized rich data have been used for establishing advanced cell and molecular research platforms needed by biotech, pharma & diagnostics companies for the development and validation of their products and marketing strategy. Clinical diagnostics for personalized medicine e.g., myPLATELET test used to optimize anti-platelet therapy for PCI-plus-stent patients, and can-Assist Breast for optimizing chemotherapy decision for hormone positive breast cancer patients, are also developed by Sapien and its samples. Unlike most biobanks in the world, Sapien is reaching sustainability. Sapien's hybrid business model of offering value-added biospecimen services such as target and biomarker validation, screening drug candidates in patient tumor-derived cells, are in high demand by innovative R&D companies, be they pharma, biotech, diagnostics or reagents & equipment companies in personalized medicine solutions arena.

Written by the company on its public Startup India profile. Not verified by us.